Published: Nov 28, 2023, 03:45 IST | Updated: Nov 28, 2023, 03:45 IST
Indian competitors are gaining from the pharmaceutical industry's efforts to reduce its dependency on Chinese suppliers of medications for clinical trials and early-stage manufacturing. Due to the low cost and quick turnaround times provided by contract drugmakers, China has been the go-to destination for a variety of pharmaceutical research and manufacturing services for almost 20 years.